Clinical and Molecular Characteristics Associated with Survival in Advanced Melanoma Treated with Checkpoint Inhibitors.
Sunil BadamiSunil UpadhayaRavi Kanth VelagapudiPushyami MikkilineniRanju KunworSamer A Al HadidiGhassan BachuwaPublished in: Journal of oncology (2018)
Checkpoint inhibitors significantly increased OS in patients with wild BRAF, positive PD-1, and high LDH. However, results should be interpreted keeping in mind associated significant heterogeneity. The results of this study should help in designing future clinical trials.